Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
5:54
"Key Insights on ASPEN: Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenström macroglobulinemia (WM) "
"Key Insights on ASPEN: Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenström macroglobulinemia (WM) "
Non-Hodgkin Lymphoma Similar Videos
-
John P. Leonard, MD; Weill Cornell Medicine #BtC_ASCO21
16:48
Dr. John Leonard discusses Recently Presented Data of Clinical Trials in Patients with NHL.
-
Ann LaCasce, MD; Dana-Farber Cancer Institute; 5Live #ASH21
5:21
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Matthew Lunning, DO, FACP; University of Nebraska Medical Center; 5Live #ASH21
4:55
Key insights from the 2021 Annual Hematology meeting in Atlanta